Improved contractile function of the mdx dystrophic mouse diaphragm muscle after insulin-like growth factor-I administration

American Journal of Pathology

Volumn 161, Issue 6, 2002, Pages 2263-2272

  Gregorevic, Paul ^a   Plant, David R ^a   Leeding, Kerri S ^a   Bach, Leon A ^a   Lynch, Gordon S ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN C; SUCCINATE DEHYDROGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIAPHRAGM MUSCLE; DOSE RESPONSE; DRUG EFFECT; DUCHENNE MUSCULAR DYSTROPHY; ENZYME ACTIVITY; MALE; MOUSE; MUSCLE CELL; MUSCLE CONTRACTION; MUSCLE FORCE; NONHUMAN; PRIORITY JOURNAL;

EID: 0036898037     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64502-6     Document Type: Article

References (42)

1. Engel AG, Yamamoto M, Fischbeck KH: Dystrophinopathies. Myology. Edited by AG Engel, C Franzini-Armstrong. New York, McGraw-Hill, 1994, pp 1133-1187
2. Hartigan-O'Connor D, Chamberlain JS: Developments in gene therapy for muscular dystrophy. Microsc Res Tech 2000, 48:223-238
3. Adams GR, Haddad F: The relationships among IGF-I, DNA content, and protein accumulation during skeletal muscle hypertrophy. J Appl Physiol 1996, 81:2509-2516
4. Marsh DR, Criswell DS, Hamilton MT, Booth FW: Association of insulin-like growth factor mRNA expressions with muscle regeneration in young, adult, and old rats. Am J Physiol 1997, 273:R353-R358
5. De Luca A, Pierno S, Camerino C, Cocchi D, Camerino DC: Higher content of insulin-like growth factor-I in dystrophic mdx mouse: Potential role in the spontaneous regeneration through an electrophysiological investigation of muscle function. Neuromusc Disord 1999, 9:11-18
6. Singleton JR, Feldman EL: Insulin-like growth factor-I in muscle metabolism and myotherapies. Neurobiol Dis 2001, 8:541-554
7. Bark TH, McNurlan MA, Lang CH, Garlick PJ: Increased protein synthesis after acute IGF-I or insulin infusion is localized to muscle in mice. Am J Physiol 1998, 275:E118-E123
8. Fang CH, Li BG, Wang JJ, Fischer JE, Hasselgren PO: Treatment of burned rats with insulin-like growth factor I inhibits the catabolic response in skeletal muscle. Am J Physiol 1998, 275:R1O91-R1O98
9. Chrysis D, Underwood LE: Regulation of components of the ubiquitin system by insulin-like growth factor I and growth hormone in skeletal muscle of rats made catabolic with dexamethasone. Endocrinology 1999, 140:5635-5641
10. Chakravarthy MV, Davis BS, Booth FW: IGF-I restores satellite cell proliferative potential in immobilized old skeletal muscle. J Appl Physiol 2000, 89:1365-1379
11. Delbono O: Regulation of excitation contraction coupling by insulin-like growth factor-1 in aging skeletal muscle. J Nutr Health Aging 2000, 4:162-164
12. Musaro A, McCullagh K, Paul A, Houghton L, Dobrowolny G, Molinaro M, Barton ER, Sweeney HL, Rosenthal N: Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nat Genet 2001, 27:195-200
13. Barton ER, Morris L, Musaro A, Rosenthal N, Sweeney HL: Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice. J Cell Biol 2002, 157:137-148
14. Matecki S, Topin N, Hayot M, Rivier F, Echenne B, Prefaut C, Ramonatxo M: A standardized method for the evaluation of respiratory muscle endurance in patients with Duchenne muscular dystrophy. Neuromusc Disord 2001, 11:171-177
15. Lynch GS, Hinkle RT, Faulkner JA: Force and power output of diaphragm muscle strips from mdx and control mice after clenbuterol treatment. Neuromusc Disord 2001, 11:192-196
16. Lynch GS, Hinkle RT, Chamberlain JS, Brooks SV, Faulkner JA: Force and power output of fast and slow skeletal muscles from mdx mice 6-28 months old. J Physiol 2001, 535:591-600
17. Stedman HH, Sweeney HL, Shrager JB, Maguire HC, Panettieri RA, Petrof B, Narusawa M, Leferovich JM, Sladky JT, Kelly AM: The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature 1991, 352:536-539
18. Dupont-Versteegden EE, McCarter RJ: Differential expression of muscular dystrophy in diaphragm versus hindlimb muscles of mdx mice. Muscle Nerve 1992, 15:1105-1110
19. Zdanowicz MM, Moyse J, Wingertzahn MA, O'Connor M, Teichberg S, Slonim AE: Effect of insulin-like growth factor I in murine muscular dystrophy. Endocrinology 1995, 136:4880-4886
20. Hsu HH, Zdanowicz MM, Agarwal VR, Speiser PW: Expression of myogenic regulatory factors in normal and dystrophic mice: Effects of IGF-1 treatment. Biochem Mol Med 1997, 60:142-148
21. Wingertzahn MA, Zdanowicz MM, Slonim AE: Insulin-like growth factor-I and high protein diet decrease calpain-mediated proteolysis in murine muscular dystrophy. Exp Biol Med 1998, 218:244-250
22. Lynch GS, Cuffe SA, Plant DR, Gregorevic P: IGF-I treatment improves the functional properties of fast- and slow-twitch skeletal muscles from dystrophic mice. Neuromusc Disord 2001, 11:260-268
23. Granchelli JA, Pollina C, Hudecki MS: Pre-clinical screening of drugs using the mdx mouse. Neuromusc Disord 2000, 10:235-239
24. Bach LA: The insulin-like growth factor system: Basic and clinical aspects. Aust N Z J Med 1999, 29:355-361
25. Vahlsing HL, Varon S, Hagg T, Fass-Holmes B, Dekker A, Manley M, Manthorpe M: An improved device for continuous intraventricular infusions prevents the introduction of pump-derived toxins and increases the effectiveness of NGF treatments. Exp Neurol 1989, 105: 233-243
26. Markowska AL, Mooney M, Sonntag WE: Insulin-like growth factor-I ameliorates age-related behavioral deficits. Neuroscience 1998, 87: 559-569
27. Lynch GS, Rafael JA, Hinkle RT, Cole NM, Chamberlain JS, Faulkner JA: Contractile properties of diaphragm muscle segments from old mdx and old transgenic mdx mice. Am J Physiol 1997, 272:C2063-C2068
28. Segal SS, Faulkner JA: Temperature-dependent physiological stability of rat skeletal muscle in vitro. Am J Physiol 1985, 248:C265-C270
29. Mendez J, Keys A: Density and composition of mammalian muscle. Metabolism 1960, 9:184-199
30. Hämäläinen, N, Pette D: The histochemical profiles of fast fiber types IIB, ID and IIA in skeletal muscles of mouse, rat and rabbit. J Histochem Cytochem 1993, 41:733-743
31. Blanco CE, Sieck GC, Edgerton VR: Quantitative histochemical determination of succinic dehydrogenase activity in skeletal muscle fibres. Histochem J 1988, 20:230-243
32. Bach LA, Jerums G: Effect of puberty on initial kidney growth and rise in kidney IGF-I in diabetic rats. Diabetes 1990, 39:557-562
33. Ballard FJ, Knowles SJ, Walton PE, Edson K, Owens PC, Mohler MA, Ferraiolo BL: Plasma clearance and tissue distribution of labelled insulin-like growth factor-I (IGF-I), IGF-II and des(1-3)IGF-I in rats. J Endocrinol 1991, 128:197-204
34. Petrof BJ, Stedman HH, Shrager JB, Eby J: Sweeney HL, Kelly AM Adaptations in myosin heavy chain expression and contractile function in dystrophic mouse diaphragm. Am J Physiol 1993, 265:C834-C841
35. Lewis MI, LoRusso TJ, Fournier M: Anabolic influences of insulin-like growth factor I and/or growth hormone on the diaphragm of young rats. J Appl Physiol 1997, 82:1972-1978
36. Delling U, Tureckova J, Lim HW, De Windt LJ, Rotwein P, Molkentin JD: A calcineurin-NFATc3-dependent pathway regulates skeletal muscle differentiation and slow myosin heavy-chain expression. Mol Cell Biol 2000, 20:6600-6611
37. 2in mouse skeletal muscle. Biophys J 2002, 82:1338-1344
38. Donovan CM, Faulkner JA: Plasticity of skeletal muscle: Regenerating fibers adapt more rapidly than surviving fibers. J Appl Physiol 1987, 62:2507-2511
39. Vlachopapadopoulou E, Zachwieja JJ, Gertner JM, Manzione D, Bier DM, Matthews DE, Slonim AE: Metabolic and clinical response to recombinant human insulin-like growth factor I in myotonic dystrophy - A clinical research center study. J Clin Endocrinol Metab 1995, 80:3715-3723
40. Festoff BW: The preclinical rationale for the use of insulin-like growth factor-I in amyotrophic lateral sclerosis. Drugs Today 1998, 34:65-77
41. Herndon DN, Ramzy PI, Debroy MA, Zheng M. Ferrando AA, Chinkes DL, Barret JP, Wolfe RR, Wolf SE: Muscle protein catabolism after severe burn: Effects of IGF-1/IGFBP-3 treatment. Ann Surg 1999, 229:713-722
42. Laron Z: Somatomedin-1 (recombinant insulin-like growth factor-1) -clinical pharmacology and potential treatment of endocrine and metabolic disorders. Biodrugs 1999, 11:55-70